Literature DB >> 28341141

Efficacy and safety of tocilizumab in neuro-Behçet's disease: A case report.

L Essaadouni1, F Zahra Ha-Ou-Nou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28341141     DOI： 10.1016/j.neurol.2017.02.006

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN： 0035-3787            Impact factor:   2.607


× No keyword cloud information.
  3 in total

Review 1.  Clinical characteristics of avascular necrosis in patients with Behçet disease: a case series and literature review.

Authors:  Nuh Atas; Berivan Bitik; Ozkan Varan; Hakan Babaoglu; Abdurrahman Tufan; Seminur Haznedaroglu; Berna Goker; Mehmet Akif Ozturk
Journal:  Rheumatol Int       Date:  2018-12-17       Impact factor: 2.631

2.  Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet's syndrome: case series and literature review.

Authors:  Jinjing Liu; Dong Yan; Zhimian Wang; Yunjiao Yang; Shangzhu Zhang; Di Wu; Lingyi Peng; Zhichun Liu; Wenjie Zheng
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-11-16       Impact factor: 5.346

Review 3.  Behçet's Disease in Children: Diagnostic and Management Challenges.

Authors:  Giorgio Costagliola; Susanna Cappelli; Rita Consolini
Journal:  Ther Clin Risk Manag       Date:  2020-06-11       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.